The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote

Fri, 20th Dec 2019 12:09

(Alliance News) - Stocks in London were mixed at midday on Friday as investors look ahead to the Brexit deal vote in Parliament in the afternoon, while the UK chancellor finally named a new governor of the Bank of England.

The FTSE 100 index was up 16.90 points, or 0.2% at 7,589.97. The mid-cap FTSE 250 index was down 60.96 points, or 0.3% at 21,605.18, and the AIM All-Share index was 0.4% higher at 941.63.

The Cboe UK 100 index was up 0.2% at 12,865.61. The Cboe 250 was 0.2% lower at 19,518.94, and the Cboe Small Companies was down 0.2% at 12,030.27.

In mainland Europe, the CAC 40 in Paris was up 0.5% and the DAX 30 in Frankfurt was up 0.6%.

"UK stocks are treading water as they eagerly await the next step in the Brexit process today. With Theresa May and Boris Johnson previously unable to pass their respective withdrawal agreements, the value of a strong parliamentary majority will become clear today as Johnson's deal looks set to sail through without a hitch. For markets this should provide some degree of certainty and confidence, yet we are instead seeing anxiety remain thanks to Johnson's hard deadline of December 2020 to conclude trade negotiations," said IG Group's Josh Mahony.

In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said it divested the rights to cancer drugs Arimidex and Casodex in a number of countries to Juvise Pharmaceuticals for up to USD198 million.

At the other end of the large cap index, NMC Health was by far the worst performer, down 21%. The Financial Times on Friday reported the UAE-focused private healthcare firm held talks to raise EUR200 million of off-balance sheet debt to fund new hospitals.

NMC has come under increased scrutiny from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing, that does not count toward its official debt levels.

NMC shares dropped on Tuesday after short selling firm Muddy Waters Capital said it had shorted the stock, commenting: "We have serious doubts about the company's financial statements, including its asset values, cash balance, reported profit, and reported debt levels."

NMC on Thursday hit back saying the Muddy Waters report was "false" and "misleading".

NMC shares have almost halved in value this week.

Royal Dutch Shell 'A' and 'B' shares were down 1.2% on Friday, after the oil major guided for a potential impairment based on "the macro outlook".

Shell is to book a post-tax impairment of USD1.7 billion to USD2.3 billion for the fourth-quarter of 2019, based on macroeconomic conditions, without giving any further details. The oil giant, London's largest listed company by market capitalisation, guided for a number of other charges which are set to hit fourth-quarter earnings.

In the Upstream unit, Shell will book USD100 million to USD200 million in charges related to well write-offs, plus a USD500 million to USD600 million deferred tax charge. Production in the segment for the last quarter of 2019 is guided between 2.78 million and 2.83 million barrels of oil equivalent per day. Production in all of 2018 was around 2.7 million barrels a day.

Still to come in the UK corporate calendar, Anglo-US cruise line operator Carnival is expected to report annual earnings this afternoon.

The pound was quoted at USD1.3035 at midday, slightly higher than USD1.3015 late Thursday, after UK economic growth in the third-quarter was revised upwards, the Office for National Statistics revealed.

Third-quarter gross domestic product expanded 0.4% from the second quarter, the ONS said, having previously reported a quarter-on-quarter figure of 0.3%. The ONS also reported a higher annual growth figure, with GDP in the third quarter rising by 1.1% compared to the prior estimate of 1.0%. Services remain the main contributor to growth, the ONS said, with construction also contributing positively.

Meanwhile, the head of the UK financial watchdog Andrew Bailey has been chosen as the next governor of the Bank of England, the Treasury announced.

Bailey's tenure at the BoE will begin on March 16 next year and will succeed Canadian Mark Carney, who took up the role in 2013. Carney has since extended his tenure twice, the second time to avoid any disruption during the UK's talks to leave the EU.

Bailey has been head of the Financial Conduct Authority since July 2016. Before that, he was chief executive of the Prudential Regulation Authority.

As part of his general election pledge to have Brexit "decided" by Christmas, UK Prime Minister Boris Johnson will bring back the EU Withdrawal Agreement Bill for its second reading in the House of Commons on Friday.

After the Conservatives won a landslide at the general election and secured an 80-seat majority last week, the vote in the afternoon is expected to pass without a hitch for the government and lay the ground for a January exit from the EU.

The euro stood at USD1.1094 at midday, down from USD1.1111 late Thursday. Against the yen, the dollar was trading at JPY109.35, firm from JPY109.28 late Thursday.

Stocks in New York were set for a subdued open on Friday. All three major US stock indices set fresh highs on Thursday amid a cooling of US-China trade tensions and a new continental trade agreement among the US, Canada and Mexico advancing in Congress.

The DJIA was called called up 0.1%, the S&P 500 index called flat and the Nasdaq Composite up 0.1%.

Ahead in the economic events calendar, there are US third-quarter GDP figures at 1330 GMT.

Brent oil was quoted at USD66.22 a barrel at the equities close, soft against USD66.50 late Thursday.

Gold was quoted at USD1,477.30 an ounce at the London equities close, little changed USD1,476.20 late Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.